Generally, there was a positive trend in the observed treatment difference at these early time points, favoring PF-06473871.
← all excerpts
A Placebo-controlled Study of PF-06473871 (Anti-Connective Tissue Growth Factor Antisense Oligonucleotide) in Reducing Hypertrophic Skin Scarring.
1
—
—